Institutional Ownership
Ascendis Pharma A/S
CUSIP K08588103COMQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
8
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Driehaus Capital Management LLC | 127.6K | $29.18M |
| 2 | Evolutionary Tree Capital Management, LLC | 9.1K | $2.07M |
| 3 | T. Rowe Price Investment Management, Inc. | 6.16M | $1.41M |
| 4 | Public Employees Retirement System Of Ohio | 5.8K | $1.32M |
| 5 | Legato Capital Management LLC | 1.7K | $399.8K |
| 6 | Price T Rowe Associates Inc /Md/ | 1.53M | $350.0K |
| 7 | Q Global Advisors, LLC | 100.0K | $22.9K |
| 8 | Sbi Securities Co., Ltd. | 3 | $686 |